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Selective Antimicrobial Modulation of Human Microbial Flora: Infection Prevention in 
Patients with Decreased Host Defense Mechanisms by Selective Elimination of 
Potentially Pathogenic Bacteria
Henri F. L. Guiot, Jos W. M. van der Meer, and From the Isolation Ward, J. A. Cohen Institute o f
Ralph van Furth Radiopathology and Radiation Protection; and the
Department o f  Infectious Diseases, University
Hospital, Leiden, The Netherlands
To reduce the frequency and severity of bacterial infection, selective antimicrobial 
modulation (SAM) was applied in 39 patients with severely decreased host defense 
mechanisms. The objective was to eliminate potentially pathogenic aerobic microorgan­
isms with minimal disturbance of the normal anaerobic bacterial flora. Elimination of 
potentially pathogenic aerobic microorganisms was easily accomplished in patients not 
infected at hospitalization. The anaerobic flora seemed to be undisturbed, and selection 
of  or overgrowth with resistant microorganisms did not occur. The microbiologic 
results of the SAM regimen correlated with the incidence of infection. Only three major 
infections occurred in 23 patients who were free of potentially pathogenic microorgan­
isms; 10 major infections occurred in 16 patients who were not free of potential 
pathogens. Seven of these 10 infections were present at hospitalization. The incidence of 
major infections was 47% in the patients on the SAM regimen and 82% in a group of 
control patients with a similar risk of infection.
Infection is one of the most serious complications 
in patients with severe bone-marrow failure. The 
severity and duration of granulocytopenia in these 
patients are correlated with the incidence of severe 
bacterial and fungal infection [1, 2]. The organ­
isms causing infection in granulocytopenic pa­
tients belong to the resident flora or are acquired 
from the hospital environment. It would seem 
logical to prevent such infections by total elimina­
tion of the resident flora with antibiotics (total an­
tibiotic modulation) and by nursing the patients in 
strict protective isolation [3]. However, apart 
from such negative aspects as discomfort for the 
patient and high costs, attempts to eliminate all 
microorganisms often fail and may lead to over­
growth with multiresistant, potentially pathogenic
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strains. Moreover, much effort is required to 
eliminate all bacteria and fungi from the patient, 
whereas in granulocytopenic patients most of the 
severe infections are caused by only a few species 
of the normal resident flora: members of the fami­
ly Enterobacteriaceae, Pseudomonas aeruginosa, 
Staphylococcus aureus, and Candida albicans. 
Although anaerobes outnumber aerobes and fac­
ultative anaerobes by a factor of 100-10,000, 
anaerobes are responsible for <10% of severe in­
fections in patients with bone-marrow failure [4].
It has been shown that anaerobes have an in­
hibitory effect on the growth of aerobic microor­
ganisms. (The latter are defined here as being both 
obligate aerobes and facultative anaerobes.) This 
effect is called colonization resistance [5-9]. If the 
anaerobic flora is disturbed by treatment of the 
patient with antibiotics, colonization resistance is 
decreased. Under these conditions, overgrowth 
with potentially pathogenic aerobic bacteria or 
fungi and selection of multiresistant microorgan­
isms may occur, and the chance of nosocomial in­
fection will increase. The concept of colonization 
resistance and the fact that it is almost impossible 
to make a patient totally germ-free led us to 
change our approach to infection prevention. A 
combination of antibiotics with activity against 
aerobes and fungi but not against anaerobes was
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chosen for administration to patients with a high 
risk of infection; this regimen has been titled selec­
tive antimicrobial modulation (SAM) [10].1
The present report describes the results of a 
clinical trial with SAM in patients with severe 
granulocytopenia. The anaerobic flora in the feces 
of patients on the SAM regimen was compared 
with that of healthy individuals to assess the extent 
of disturbance caused by the regimen.
Patients and M ethods
Patients. Between 1975 and 1978, 50 patients 
were admitted to the isolation ward of the Univer­
sity Hospital in Leiden, The Netherlands. These 
patients were treated for diseases associated with 
bone-marrow failure and were placed on a regimen 
of SAM and protective isolation as additional 
care. Most of these patients were assigned to this 
special ward because their risk for infection was 
expected to be extremely high. Of this group, 
39 patients with severe granulocytopenia (<100 
granulocytes/mm3) for more than seven days are 
included in the present report (SAM group). Seven 
patients have already been described [10].
During the first six months of 1976, 31 other pa­
tients were treated for diseases associated with 
bone-marrow failure. They could not be assigned 
to the special isolation ward and were not placed 
on the SAM regimen. Their only protection con­
sisted of conventional isolation in single rooms. In 
these patients the quantitative relationship be­
tween circulating leukocytes and infection was 
previously described by van der Meer et al. [2]. 
Only the 14 patients in this group who had severe 
granulocytopenia (<100 granulocytes/mm3) for 
more than seven days are briefly discussed herein 
for purposes of comparison (control group).
Therapy fo r  hematologic disorder. In the 
SAM group, 15 patients with acute myeloid leuke­
mia (AML) were treated with the LAM V remis- 
sion-induction regimen.2 Eleven patients under­
went bone-marrow transplantation (BMT) [11] for 
treatment of AML, acute lymphocytic leukemia
1 In previous publications the regimen has been known as 
partial antibiotic decontamination.
2 The LAM V treatment protocol (no. 06781) o f  the Euro­
pean Organization for Research on Treatment o f  Cancer (Zu­
rich, Switzerland) consists of  vincristine, doxorubicin, and cy- 
tarabine.
(ALL), or severe aplastic anemia (AA). Thirteen 
patients with AA were treated with antithymocyte 
globulin [12]. In the control group, 11 patients 
were treated with the LAM V regimen for AML, 
two patients with androgens for AA, and one with 
corticosteroids for AA.
Isolation o f  patients on the SA M  regimen. 
The first six patients of the SAM group were nursed 
in strict protective isolation (including sterile 
food) in laminar down-flow isolators or other 
equivalent systems. The isolation measures for the 
next 13 patients were progressively reduced. The 
last 20 patients were isolated in “open” systems: 
one of the plastic curtains of the laminar-flow 
system was constantly kept open about 75 cm. The 
patient was allowed to leave the isolator while he 
or she was wearing a well-fitting mask to take 
some exercise or a shower and to have contact 
with nonsterilized dry and clean articles (daily 
newspaper, letters, and cigarettes). Of these 20 pa­
tients, 10 were placed on the SAM regimen at 
home during short periods (four to 14 days) of 
partial hematologic remission. The last 20 patients 
were given food with a low bacterial level. The 
isolation units were disinfected with 70% alcohol 
twice a week. The shower was rinsed with hot 
water before use, dried carefully after use, and 
disinfected with 70% alcohol twice a week because 
bacteriologic control suggested that contamina­
tion of the skin with P. aeruginosa could occur 
there. Sterile nursing was initially (first six pa­
tients) performed by two nurses but was later 
changed to aseptic handling by one nurse. Clothes 
for the nursing staff were not sterilized but were 
washed in the central hospital laundry at 90 C.
Isolation o f  control patients. The control pa­
tients were conventionally isolated in single 
rooms, without laminar-flow air. They were given 
the normal hospital food.
SA M  regimen. Four times a day the naso­
pharyngeal region was sprayed with an aqueous 
solution of 3% gentamicin. One gram of an oint­
ment composed of 3% amphotericin B, 3% neo­
mycin, and 1% polymyxin B in oral protective 
paste (Orabase®; Squibb B.V., Rijswijk, The 
Netherlands) was applied to the mouth. The oint­
ment was used as a toothpaste with menthol fla­
voring and applied with a toothbrush. The SAM 
regimen of the gastrointestinal tract consisted of 
250 mg of neomycin, 250 mg of amphotericin B, 
100 mg of polymyxin B, and 1,000 mg of nalidixic
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acid, all given orally four times a day. The skin 
was washed daily with either povidone-iodine soap 
(even days) or water containing 0.02% chlorhex- 
idine (odd days). The prepuce or vulval and vagi­
nal region was treated with a cetyl-based cream 
containing the same composition of antibiotics as 
the ointment used for the mouth. For macroscop- 
ically detectable C. albicans persisting in the 
mouth, a gentian violet solution was used. Per­
sisting potential pathogens on the skin were 
treated daily with silver sulfadiazine.
In 15 patients the complete SAM regimen was 
not followed during short periods (eight to 14 
days); either lower dosages were given during cy­
totoxic therapy (because of nausea) or nalidixic 
acid was omitted temporarily if hypersensitivity 
due to the drug was suspected.
Management o f  infections. In both the SAM 
patients and controls, systemic antibiotic treat­
ment was not instituted until infection was seri­
ously suspected or proven. The choice of antibi­
otics was governed by the site of the infection and 
the suspected causative microorganisms. Initial 
therapy almost always consisted of a combination 
of two antibiotics given iv. Whenever possible, an­
tibiotic therapy was adjusted on the basis of the 
results of bacteriologic investigations.
Definition o f  infections. Infections were 
divided into bacterial, fungal, viral, and proto­
zoan infections. The bacterial and fungal infec­
tions were divided into minor infections —clinical 
infections on the skin or mucosa without exten­
sion to deep tissues (stomatitis, gingivitis, sinusi­
tis, and pharyngitis), whether microbiologically 
proven or not —and major infections —clinical in­
fections with extension to deep tissue or organs 
(pneumonia and pyelonephritis) and septicemia, 
whether microbiologically proven or not. Infec­
tions were called doubtful if all diagnostic pro­
cedures did not give conclusive results and only 
the patient’s clinical condition (fever) was sug­
gestive of infection.
Microbiologic investigation. A bacteriologic 
inventory of the SAM patients was carried out 
twice a week. Samples of feces and urine and 
swabs from the nose, oropharynx, axilla, groin, 
and prepuce or vagina were cultured on selective 
and nonselective media (Oxoid, London, En­
gland, and Difco Laboratories, Detroit, Mich.). 
Samples from infected areas were cultured by 
standard bacteriologic methods. During periods
of fever (axillary temperature, >38 C), at least two 
blood samples were cultured daily, both aerobically 
and anaerobically. The microbiologic surveillance 
has been described in detail by Guiot and van 
Furth [10].
Anaerobic flora. Gram-stained smears of fec­
al samples obtained twice a week were examined 
with a microscope. In addition, the anaerobic 
fecal flora of 22 patients on the SAM regimen was 
compared with that of 21 healthy individuals 
(nurses, physicians, and technicians) to obtain 
quantitative and qualitative information about the 
composition of the anaerobic flora during SAM. 
The fecal flora was investigated after the patient 
had been on the SAM regimen for at least four 
weeks. Only patients without diarrhea (graft-vs.- 
host disease [11]) and receiving no antibiotics ex­
cept those in the SAM regimen were investigated. 
Only one fecal sample of each individual was ob­
tained. For this purpose, about 1 g of feces was 
suspended and homogenized in 9 ml of prereduced 
anaerobic brain-heart infusion broth (Oxoid) 
(adapted by the method of Holdeman and Moore 
[13]). From this suspension a series of 10-fold 
dilutions was prepared. For half of the patients 
and healthy individuals, cfu counts were performed 
(10-7, 10~8, and 10"9 dilutions) on aerobic sheep 
blood agar (Oxoid), Eugon agar (Becton, Dickin­
son and Co., Cockeysville, Md.), Schaedler agar 
(Bio-Mérieux, Charbonières-les-Bain, France), 
and anaerobic brain-heart infusion broth. For the 
other half of both groups, suspension cultures 
were made of all dilutions (10_1-10"12). Anaerobic 
conditions were obtained with the GasPak® 
system (Becton, Dickinson and Co.) and the open- 
tube technique [13]. Isolates were identified on the 
basis of morphologic characteristics; the produc­
tion of volatile fatty acids, lactic acid, succinic 
acid, gas, N H 3, indole, and catalase; and the 
fermentation of glucose, lactose, ribose, and 
starch [13].
Pattern o f  volatile fatty  acids in feces. In addi­
tion to the bacteriologic inventory, the metabolic 
activity of the anaerobic flora was investigated. 
For this purpose, about 5 g of feces from patients 
on the SAM regimen and from healthy individuals 
was suspended in 10 ml of water. The suspension 
was mixed thoroughly and centrifuged for 15 min 
at 4.95 g. The supernatant was decanted and fil­
tered through a coarse paper filter, and 1 ml of 
ether and 0.5 ml of 2 n  HC1 were added. The tube
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was stoppered and kept at 4 C for about 30 min 
before it was centrifuged at 4.95 g for 15 min. This 
sample was kept at - 2 0  C until the remaining 
water froze. Estimation of the amounts of volatile 
fatty acids was performed by gas chromatography 
with a glass column (length, 175 cm; diameter, 0.2 
cm) filled with Chromosorb® W-AW (Sulpelco, 
Bellefonte, Pa.). The temperature of the column 
was 120 C, that of the injector and detector ports, 
150 C and 170 C, respectively. The carrier gas was 
N2 under a pressure of 0.8 kg/cm 2. Five micro­
liters of the ether supernatant was injected for gas 
chromatography.
Fecal flora fo r  anaerobic reconstitution. For 
reconstitution of anaerobic flora, 5 g of feces 
from a decontaminated patient without gastroin­
testinal complaints and with a fecal flora of nor­
mal appearance by microscopy was suspended in
0.85% NaCl. The suspension was homogenized by 
shaking for 30 sec and then centrifuged at a low
speed (5 min at 1 g). The supernatant was filtered 
through a layer (3-5 cm) of cotton wool to remove 
the coarse particles and then centrifuged at a 
higher speed (15 min at 4.95 g). The pellet was sus­
pended in 5 ml of 0.85% NaCl, and 1 ml of this 
suspension was mixed into 100 ml of chilled choc­
olate milk that was then swallowed by the patient 
within 1 hr of preparation.
Results
Clinical details o f  the group o f  patients on the 
SAM  regimen. Clinical details concerning the 
SAM group are given in table 1. The mean ages of 
the patients with AML and AA were similar, where­
as the mean age of the patients with BMT was con­
siderably younger. The mean number of granulo­
cytopenic days was about the same for the patients 
with AML and AA, whereas the patients with 
BMT had a shorter period of granulocytopenia.
Table 1. Clinical details of 39 patients with severely decreased host defense mechanisms who were placed on a regi­
men of selective antimicrobial modulation.
Patients with
Parameter
Acute myeloid 
leukemia (n = 15)
Aplastic anemia 
(n = 13)
Bone-marrow trans­
plantation (n = 11)
Age (years)
Mean 37.3 35.8 22
Median 37 33 20.5
Range 19-55 15-84 16-44
No. of  granulocytopenic days 
<100 granulocytes/mmJ
Mean 35.3 34.5 26.8
Median 28 30.5 20
Range 14-68 18-76 18-62
<500 granulocytes/mm3
Mean 52.2 58 38.5
No. of  infections present at hospitalization
Minor 3 2 2
Major 2 3* 0
Doubtful 1 0 1
No. of  newly acquired infections
Minor 4 1 1
Major 5 t 2 1
Doubtful 0 0 1
No. o f  viral infections 0 1 4
No. o f  fatal cases due to
Bacterial infection 2 2 0
Other causest 2 1 3
No. of  patients with partial hematologic cure 9 6 11
* Two patients died.
t  Two patients died of infections that originated from minor local infections present at hospitalization, 
t  There were no fatal cases of  fungal infection.
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Infections present at hospitalization. Seven 
patients were admitted with minor infections: five 
localized in the oral region and one in the rectal 
area plus one case of furuncles. Two of these pa­
tients (both with AML) developed fatal septicemia 
shortly after their first course of remission-induc- 
tion therapy, presumably originating from the 
local smoldering infection (determined at autopsy 
to be pharyngitis due to P. aeruginosa and rectal 
infiltration with Escherichia coli). The other 
minor infections were cured with narrow-spectrum 
antibiotics without further problems. Of the five 
patients hospitalized with a major infection, four 
had septicemia (two due to P. aeruginosa and two 
due to E. coli), and one had pneumonia (unknown 
etiology). Two of these patients, both with AA, 
died of septicemia before hematologic therapy 
could even be started. The other major infections 
(in patients with AML) were cured with systemic 
antibiotic treatment within a few days; the fifth 
patient (with AA) needed four weeks to become 
free of infection.
Infections acquired after hospitalization. The 
six minor infections that developed after hospitali­
zation were all localized in the oral region. These 
infections were caused by the anaerobic flora of 
the mouth and responded rapidly to penicillin G. 
Of the eight major infections that developed after 
hospitalization, two originated from smoldering 
minor infections that had been present at hospital­
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ization (described in the foregoing), and six were 
newly acquired. Five of the latter started as skin 
infections: one case of cellulitis and one of ec­
thyma gangrenosum (both exogenous skin infec­
tions with P. aeruginosa followed by sepsis [14]); 
one iv catheter infected with E. coli (which per­
sisted, even though the organism was sensitive to 
the antibiotics included in the SAM regimen); one 
case of an extensive lesion due to herpes simplex 
virus secondarily infected with Proteus mirabilis 
(which persisted because the patient had not been 
given nalidixic acid); and one case of anaerobic in­
fection of a rectal fistula (the SAM regimen was 
successful, however, with only anaerobes and 
streptococci persisting in the feces). A major in­
fection occurred in a patient who was refractory to 
therapy for leukemia; her death was the result of 
bleeding, infection, and leukemia. The death of 
this patient is classified as due to other causes in 
table 1 and due to a combination of infection and 
bleeding in figure 1. Except for the last case, all of 
these infections responded rapidly to systemic an­
tibiotic treatment directed against the causative 
agents.
Fever. Figure 1 shows the relationship be­
tween some clinical parameters by superimposi­
tion of separate diagrams for the number of pa­
tients on the SAM regimen (<500 granulocytes/ 
mm3 most of the time), the number of patients 
with severe granulocytopenia (<100 granulocytes/
Figure 1. Occurrence of granulo­
cytopenia and fever in patients with 
severely decreased host defense 
mechanisms who were placed on a 
regimen of selective antimicrobial 
modulation (SAM). Patients were 
withdrawn from the SAM regimen 
over the study period because of rela­
tive hematologic recovery, with­
drawal from further treatment of the 
underlying disease, or death (due to 
bacterial or fungal infection [solid 
cross], bleeding and infection [cross 
with solid horizontal bar], or other 
causes [open cross]) during or within 
two weeks of ending SAM. Patients 
on the SAM regimen = (□ ) ;  patients 
on the SAM regimen with <  100 gran­
ulocytes/mm3 = (CD); patients on the 
SAM regimen with fever (axillary 
temperature, >38 C) = (111); and pa­
tients on the SAM regimen with fever 
and infection = (QI).
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mm3), the number of patients with fever (axillary 
temperature, >38 C), and the number of patients 
with fever and infection. During the study, the 
number of patients with fever decreased from 13 
of 39 patients given SAM in the first week to eight 
of 36 in the third week, although the number of 
patients with severe granulocytopenia (<100 gran­
ulocytes/mm3) increased during that period from 
13 of 39 to 26 of 36 patients on the SAM regimen. 
After the first three weeks, the association between 
severe granulocytopenia and fever stabilized: about 
half of the patients on the SAM regimen had severe 
granulocytopenia, and about 30% had fever. Bac­
terial infection as the main cause of death was 
only seen in the first three weeks, although 50% of 
the patients had <100 granulocytes/mm3 for more 
than four weeks.
The reduction in fever due to bacterial or fungal 
infection in severely granulocytopenic patients is 
shown in detail in figure 2. After the first week, 
<25% of the patients with severe granulocytopenia 
had fever due to or probably due to infection.
Mortality. Four patients died as the result of a 
bacterial infection (table 1). Other causes of death 
(six patients) were graft-vs.-host disease, nonin- 
fectious interstitial pneumonia after total-body ir­
radiation, endogenous viral infection, and bleed­
ing due to persisting bone-marrow failure. None
total number of patients with 
granulocyte counts <100/mm3
Figure 2. Occurrence of fever (axillary temperature, 
>38 C) during periods of severe granulocytopenia in pa­
tients with severely decreased host defense mechanisms 
who were placed on a regimen of selective antimicrobial 
modulation. There were initially 39 patients enrolled, 
but the number decreased because of relative hemato­
logic recovery, withdrawal from further treatment of the 
underlying disease, or death. Percentage of patients with 
severe granulocytopenia at each interval who also had 
fever due to or probably due to bacterial or fungal infec­
tion = (&2).
Table 2. Relationship between microbiologic success 
of a regimen of selective antimicrobial modulation and 
clinical results in 39 patients with severely decreased host 
defense mechanisms.
No. of  weeks needed to 
eliminate potentially 
pathogenic aerobic 
microorganisms
Infection parameter <1 >1
Infected at hospitalization
Minor 3 4
Major 0 5
Not infected at hospitalization 20* 7 t
Major infection
At hospitalization 0 5
Acquiredt 3 5
No major infection 20* § 6 1§
Fatal infection 0 4
Nonfatal infection 23II 12Ü
* Two patients with doubtful infection included.
t  One patient with doubtful infection included.
t  Minor infection that had been present at hospitalization 
deteriorated or newly acquired infection.
§ P  = 0.0037 by Fisher’s exact probability test for com­
parison.
II P  =  0.004 by Fisher’s exact probability test for compari­
son.
of the patients hospitalized without an initial in­
fection died of a bacterial or fungal infection.
Microbiologic results related to occurring in­
fections. The SAM regimen was not totally suc­
cessful in the patients who were already infected at 
hospitalization; only three of 12 patients infected 
at hospitalization were free of aerobic potential 
pathogens within one week (tables 2 and 3). In the 
other nine patients, either a potentially pathogen- 
free state was not reached (five patients) or a 
longer period was required to accomplish reduc­
tion of pathogens with SAM. Major infections as 
well as fatal infections were significantly more 
common in patients who were not free of potential 
pathogens within one week (P  <  0.004; table 2). 
The persisting, potentially pathogenic aerobic 
strains (table 3) in particular were involved in in­
fection. These strains persisted although they were 
sensitive to the antibiotics used in the SAM regi­
men. They were mainly isolated from oral or skin 
swabs, often in small numbers and not from all 
samples.
Comparison o f  SA M  group to control group. 
The control group consisted of 14 patients whose
10 15 weeks
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microscopy. Because animal experiments and ex­
perience with patients have indicated that success­
ful oral implantation of anaerobic flora is possible 
[15], the effect of reconstitution was only con­
trolled on the basis of fecal smears.
0
The taste and appearance of the chocolate milk 
were not distinguishable from those of normal 
chocolate milk.
Discussion
The data presented in this report were obtained in 
a trial of SAM in patients with severe granulocy­
topenia (<100 granulocytes/mm3). Patients with 
less than seven days of severe granulocytopenia 
were excluded from the study. Infection at 
hospitalization was not a reason for exclusion. 
The effect of SAM was evaluated by comparison 
of a group of patients who were on the SAM 
regimen to a control group of patients who were 
not. For clarity, the SAM group will be discussed 
as a whole, although the patients with BMT prob­
ably had less risk of developing an infection than 
those with AML or AA because this subgroup had 
a lower mean age and fewer granulocytopenic 
days. A reduction in the number of major and 
fatal infections was accomplished in the SAM 
group, but this reduction holds when only patients 
with AML are compared. The meaning of this re­
duction becomes clearer when it is taken into ac­
count that in the SAM group death due to infec­
tion occurred within the first three weeks after 
hospitalization and only in patients who were in­
fected at hospitalization (figure 1). The reduction 
in the number of days with fever in the SAM pa­
tients is consistent with the finding of reduced in­
fectious complications. It must be noted that in 
the SAM group fever not related to infection oc­
curred more frequently because of complications 
associated with BMT and treatment with antithy­
mocyte globulin. Therefore, the decrease in the 
number of days with fever due to infection in the 
first four weeks of the SAM regimen is remarkable 
because the number of patients with severe granu­
locytopenia increased during that time (figures 1 
and 2).
The microbiologic results of the SAM regimen 
correlated with the incidence of infection (tables 2 
and 3). A state in which the patient was free of po­
tentially pathogenic aerobic bacteria was less easi­
ly achieved when there was an infection at the 
beginning of the SAM regimen. If a potential 
pathogen-free state was achieved, the incidence of 
major infection was relatively low from that time 
on. In most instances when the SAM regimen was 
successful, the potentially pathogenic aerobic bac­
teria (table 3) were definitely eliminated within 
one week, and the anaerobic flora was not dis­
turbed. The persisting anaerobic flora was prob­
ably involved in a few minor infections and one 
major infection.
Clearly, even when the SAM regimen is success­
ful, vigilance to detect the onset of an anaerobic 
infection (oropharyngeal and perirectal areas) 
continues to be very important. Besides the anaer­
obic flora, Staphylococcus epidermidis, Strepto­
coccus faecalis, other streptococci, and C. albi­
cans persisted. These microorganisms were present 
in normal or subnormal numbers and were not in­
volved in major infections. Because the persis­
tence of potentially pathogenic aerobic bacteria 
seems to have been correlated with infection in our 
patients, we are now inclined to administer a sys­
temic narrow-spectrum antimicrobial agent di­
rected against the persisting strains during a lim­
ited time, even if infection cannot be conclusively 
diagnosed and particularly when the patient has 
severe granulocytopenia.
It may be that the numbers of anaerobic bacte­
ria were normal because no significant differences 
were found between the level of anaerobic bacteria 
in fecal samples of patients on the SAM regimen 
and those of healthy individuals. Therefore, the 
risk of severe gastrointestinal complications due to 
disturbance of the flora [16-20] induced by the an­
tibiotics in the SAM regimen probably is very 
small. It is not clear why the levels of acetic acid 
and /7-butyric acid in feces were lower in the pa­
tient group. Small changes in the patient’s bacteri­
al flora, not detectable with the methods we used, 
may have conceivably contributed to this decrease. 
On the other hand, decreased appetite due to cyto­
toxic therapy in the SAM group may have contrib­
uted to the reduction of acid in the feces.
Some investigators [7, 8] have suggested that 
volatile fatty acids are the main factors responsible 
for the selective inhibition of aerobic and faculta­
tive anaerobic bacteria in the intestine. Probably 
there is competition for nutrients (authors’ unpub­
lished observation) that contributes to the selective
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inhibition that has been called colonization resis­
tance by van der Waaij and Berghuis [9]. If this 
hypothesis is correct, one might expect that the 
colonization resistance of patients on the SAM 
regimen would not be dramatically reduced be­
cause both volatile fatty acids and large numbers 
of anaerobes were demonstrated in fecal samples 
of patients on the SAM regimen. Indeed, the mi­
crobiologic condition of most of the SAM patients 
was stable; overgrowth with multiresistant, poten­
tially pathogenic aerobic microorganisms did not 
occur except in the two patients with AA hospital­
ized with septicemia who were completely colonized 
by P. aeruginosa before the SAM regimen was 
started.
Most of the patients tolerated the SAM regimen 
rather well. Complaints of a bad taste or nausea 
were mild, and difficulty in swallowing the anti­
biotic capsules or nalidixic acid tablets mainly 
occurred during periods of intensive cytotoxic 
treatment.
As a result of the reduction in isolation mea­
sures, most of the patients felt relatively comforta­
ble. There was no indication, with exception of the 
two patients with exogenous P. aeruginosa infec­
tions on the skin, that the reduced isolation mea­
sures had an unfavorable effect on the bacteri- 
ologic or clinical results. These two cases of P. 
aeruginosa infections had probably originated 
from small lesions on the skin of the foot, which 
became contaminated while the patients were 
showering. Since that time disinfection of the 
shower has been included in our isolation mea­
sures. The extent to which further reduction of 
isolation is permissible is difficult to determine. 
Dietrich et al. [21] demonstrated a reduction in 
pulmonary infection in isolated patients; remark­
ably, none of our patients in the SAM group de­
veloped a bacterial or fungal pulmonary infection 
after hospitalization.
Although there have been many trials of infec­
tion prevention, the outcomes of several large- 
scale, prospective, controlled studies [21-23] were 
not consistent, and further studies have been un­
dertaken in other centers. If stringent methods 
such as strict protective isolation and total antimi­
crobial modulation (with or without systemic anti­
biotics) are to be recommended, there must be 
proof not only that the clinical effect is favorable, 
but also that unfavorable effects such as discom­
fort, psychological stress [24, 25], nausea, and 
costs are in proportion to the final prolongation of 
survival. Probably the benefit of strict infection- 
control procedures will be hard to show for pa­
tients with a poor prognosis, like those with AML. 
On the basis of divergent arguments, several other 
centers continued clinical research in this field, re­
sulting in very aggressive methods of infection 
prevention [26] or more moderate methods similar 
to the SAM regimen [27-29]. The SAM regimen 
seems to be an adequate method for infection 
prevention in our hospital, but it remains to be 
proven that SAM can have the same favorable ef­
fect in hospitals with restricted facilities for pro­
tective isolation and bacteriologic control.
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